Basic Information 【 display / non-display

YAMAMOTO Yuzo

写真a

Affiliation

Graduate School of Medicine , Doctorial Course in Medicine , Oncoregulatory Medicine

Title

Professor

Postal address

Hondo 1-1-1, Akita, Japan

Research Fields, keywords

Hepatobililary pancreatic surgery

Homepage URL

http://www.hos.akita-u.ac.jp/

Academic Background (Undergraduate Level) 【 display / non-display

  • Kyoto University   Faculty of Medicine   1982.03  Graduated

Academic Background (Graduate Level) 【 display / non-display

  • Kyoto University  Graduate School,Division of Medicine  Doctor's Degree Program  1991.03  Accomplished credits for doctoral program

Professional Career On-Campus 【 display / non-display

  • 2009.04
    -
     

    Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Oncoregulatory Medicine   Professor

  • 2003.03
    -
    2009.03

    Akita University   School of Medicine   School of Medicine   Professor

 

Articles 【 display / non-display

  • Ante-situm hepatic resection for tumors involving the confluence of hepatic veins and IVC.

    Yamamoto Y.

    J Hepatobilliary Pancreat Sci   20 ( 3 )   313 - 323   2013.03

  • Enhancement of the liver regeneration by ATP-sensitive K+ channel opener (diazoxide) after partial hepatectomy.

    Nakagawa Y, Yoshioka M, Abe Y, Uchiami H, Ohba T, Ono K, Yamamoto Y.

    Transplantation   93 ( 11 )   1094 - 1100   2012.06

  • Meloxicam, a COX-2 inhibitor, ameliorates ischemia/reperfusion injury in non-heart-beating donor livers.

    Stoffels B, Yonezawa K, Yamamoto Y, Schaefer N, Overhaus M, Klinge U, Kalff JC, Minor T, Tolba RH.

    Eur Surg Res   47   109 - 117   2011.10

  • Change in the fatty acid composition of the liver with the administration of n-3 poly unsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver.

    Iwasaki W, Kume M, Kudo K, Uchinami H, Kikuchi I, Nakagawa Y, Yoshioka M, Yamamoto Y.

    Shock   33 ( 3 )   306 - 314   2010.03

  • Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228(FK228), on adenovirus-mediated transgene expression.

    Taura K, Yamamoto Y, Nakajima A, Hata K, Uchinami H, Yonezawa K, Hatano E, Nishino N, Yamaoka Y.

    J Gene Med   6 ( 5 )   526 - 536   2004.05

display all >>